22P HER2-low vs HER2-zero metastatic breast carcinoma: A clinical and genomic descriptive analysis

• DOI: 10.1016/j.annonc.2021.03.036
• Publication Date: 2021-05-08T12:56:23Z
• Authors: R. Sanchez Bayona; A.M. Luna; P. Tolosa; A. Sánchez De Torre; A. Castelo; M. Marín; C. García; V. Boni; E. Bernal Hertfelder; E. Vega; B. Rojas; R. Bratos; M. Martínez; Á.J. Díaz Bermejo; L. Lema; L. Manso; E.M. Ciruelos
• Keywords: 03 medical and health sciences; 0302 clinical medicine